Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | 104.02 Million USD | 374.05% |
| 2021 | 6.58 Million USD | -87.22% |
| 2020 | 76.83 Million USD | 45.7% |
| 2019 | 52.73 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | 10.28 Million USD | -77.17% |
| 2023 Q3 | 16.35 Million USD | -56.65% |
| 2023 Q2 | 37.71 Million USD | 266.66% |
| 2022 FY | - USD | 374.05% |
| 2022 Q4 | 45.05 Million USD | 110.93% |
| 2022 Q3 | 21.35 Million USD | 48.62% |
| 2022 Q2 | 14.37 Million USD | 150.98% |
| 2022 Q1 | 5.72 Million USD | 118.41% |
| 2021 Q1 | 3.42 Million USD | -90.87% |
| 2021 FY | - USD | -87.22% |
| 2021 Q2 | 18.99 Million USD | 454.44% |
| 2021 Q4 | -31.09 Million USD | -242.99% |
| 2021 Q3 | 21.74 Million USD | 14.49% |
| 2020 Q4 | 37.52 Million USD | 128.47% |
| 2020 Q3 | 16.42 Million USD | -21.32% |
| 2020 Q1 | -4.86 Million USD | 0.0% |
| 2020 FY | - USD | 45.7% |
| 2020 Q2 | 20.87 Million USD | 529.51% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 66.261% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | 4524.779% |
| Embecta Corp. | 245.4 Million USD | 57.609% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 36.139% |
| PainReform Ltd. | -9.56 Million USD | 1187.125% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 2820.074% |
| SCYNEXIS, Inc. | 73.47 Million USD | -41.574% |
| Journey Medical Corporation | 1.92 Million USD | -5315.252% |
| Safety Shot Inc | -12.18 Million USD | 953.717% |
| Alpha Teknova, Inc. | -25.53 Million USD | 507.326% |
| Bright Green Corporation | - USD | -Infinity% |
| Alvotech | -484.86 Million USD | 121.455% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 4.842% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | -8700.931% |
| Cosmos Health Inc. | -17.06 Million USD | 709.707% |
| Dynavax Technologies Corporation | 9.66 Million USD | -976.216% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 169.301% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 165.486% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 2820.074% |
| Theratechnologies Inc. | -10.31 Million USD | 1108.718% |
| Harrow Health, Inc. | 9.72 Million USD | -969.906% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | 2398.939% |
| Biofrontera Inc. | -18.45 Million USD | 663.74% |
| DURECT Corporation | -24.68 Million USD | 521.435% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | -5.867% |
| Cronos Group Inc. | -72.14 Million USD | 244.184% |
| OptiNose, Inc. | -15.55 Million USD | 768.855% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 111.248% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 388.307% |
| RedHill Biopharma Ltd. | 26.26 Million USD | -296.05% |
| Organogenesis Holdings Inc. | 36.03 Million USD | -188.715% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | 2752.157% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | 14734.17% |
| Radius Health, Inc. | 38.31 Million USD | -171.54% |
| Universe Pharmaceuticals INC | -3.21 Million USD | 3335.607% |
| ProPhase Labs, Inc. | -14.82 Million USD | 801.605% |
| Phibro Animal Health Corporation | 84.6 Million USD | -22.953% |
| Procaps Group S.A. | 104.02 Million USD | 0.0% |
| TherapeuticsMD, Inc. | -8.4 Million USD | 1338.269% |
| Viatris Inc. | 3.51 Billion USD | 97.042% |
| Rockwell Medical, Inc. | -4.69 Million USD | 2316.17% |
| Aytu BioPharma, Inc. | -1.01 Million USD | 10379.348% |
| SIGA Technologies, Inc. | 84.15 Million USD | -23.607% |
| Tilray Brands, Inc. | -72.84 Million USD | 242.81% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | -12711.207% |
| Shineco, Inc. | -26.55 Million USD | 491.758% |
| PetIQ, Inc. | 81.48 Million USD | -27.662% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | 2975.558% |
| Incannex Healthcare Limited | -18.5 Million USD | 662.187% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 75.0% |
| Alimera Sciences, Inc. | 7.27 Million USD | -1329.728% |
| Silver Spike Investment Corp. | 7.34 Million USD | -1317.24% |
| Assertio Holdings, Inc. | -222.44 Million USD | 146.765% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | 2706.769% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | 2569.852% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 719.061% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 619.336% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 169.758% |
| Hempacco Co., Inc. | -12.77 Million USD | 914.412% |
| Talphera, Inc. | -9.84 Million USD | 1156.97% |
| Alvotech | -484.86 Million USD | 121.455% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | -34.225% |
| Lantheus Holdings, Inc. | 491 Million USD | 78.813% |
| Currenc Group, Inc. | -1.9 Million USD | 5573.452% |
| Kamada Ltd. | 21.53 Million USD | -383.083% |
| Indivior PLC | 66 Million USD | -57.617% |
| Evoke Pharma, Inc. | -7.29 Million USD | 1526.533% |
| Flora Growth Corp. | -45.87 Million USD | 326.787% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 619.336% |
| Evolus, Inc. | -41.81 Million USD | 348.809% |
| HUTCHMED (China) Limited | 25.52 Million USD | -307.502% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 56.918% |
| Akanda Corp. | -27.73 Million USD | 475.066% |